# NGM BIOPHARMACEUTICALS INC (NGM)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/NGM/

- Reporting holders: 72
- Reported value: $55.7M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Column Group LLC](https://holderbook.com/funds/1833486-column-group-llc/) | $28.8M | 18,136,735 | 18.0% | 14 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $4.8M | 3,004,210 | 0.0% | 20 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $3.7M | 2,324,392 | 0.0% | 20 |
| [StepStone Group LP](https://holderbook.com/funds/1502287-stepstone-group-lp/) | $2.5M | 1,573,357 | 0.5% | 11 |
| [Euclidean Capital LLC](https://holderbook.com/funds/1825034-euclidean-capital-llc/) | $1.6M | 992,168 | 0.2% | 14 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $1.6M | 983,836 | 0.0% | 20 |
| [Trium Capital LLP](https://holderbook.com/funds/1963860-trium-capital-llp/) | $1.6M | 977,965 | 0.6% | 1 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $1.3M | 823,111 | 0.0% | 20 |
| [ADAR1 Capital Management, LLC](https://holderbook.com/funds/1940272-adar1-capital-management-llc/) | $1.3M | 816,581 | 0.3% | 1 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $972.0K | 611,300 | 0.0% | 11 |
| [TWO SIGMA ADVISERS, LP](https://holderbook.com/funds/1478735-two-sigma-advisers-lp/) | $804.4K | 505,900 | 0.0% | 13 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $741.6K | 466,386 | 0.0% | 19 |
| [NORTHERN TRUST CORP](https://holderbook.com/funds/73124-northern-trust-corp/) | $592.6K | 372,733 | 0.0% | 20 |
| [Balyasny Asset Management L.P.](https://holderbook.com/funds/1218710-balyasny-asset-management-l-p/) | $573.4K | 360,599 | 0.0% | 1 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $545.7K | 342,195 | 0.0% | 20 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](https://holderbook.com/funds/884546-charles-schwab-investment-management-inc/) | $452.6K | 284,649 | 0.0% | 20 |
| [GOLDMAN SACHS GROUP INC](https://holderbook.com/funds/886982-goldman-sachs-group-inc/) | $332.8K | 209,298 | 0.0% | 20 |
| [EXCHANGE TRADED CONCEPTS, LLC](https://holderbook.com/funds/1457320-exchange-traded-concepts-llc/) | $296.1K | 186,232 | 0.0% | 4 |
| [NATIXIS](https://holderbook.com/funds/1274981-natixis/) | $288.4K | 181,366 | 0.0% | 1 |
| [BNP PARIBAS FINANCIAL MARKETS](https://holderbook.com/funds/1166588-bnp-paribas-financial-markets/) | $272.5K | 171,397 | 0.0% | 20 |
| [DIMENSIONAL FUND ADVISORS LP](https://holderbook.com/funds/354204-dimensional-fund-advisors-lp/) | $245.6K | 154,456 | 0.0% | 16 |
| [Bank of New York Mellon Corp](https://holderbook.com/funds/1390777-bank-of-new-york-mellon-corp/) | $211.8K | 133,225 | 0.0% | 20 |
| [CITIGROUP INC](https://holderbook.com/funds/831001-citigroup-inc/) | $170.9K | 107,481 | 0.0% | 20 |
| [Connor, Clark & Lunn Investment Management Ltd.](https://holderbook.com/funds/1596800-connor-clark-lunn-investment-management-ltd/) | $155.9K | 98,037 | 0.0% | 1 |
| [Nuveen Asset Management, LLC](https://holderbook.com/funds/1521019-nuveen-asset-management-llc/) | $149.7K | 94,178 | 0.0% | 20 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 72 | $55.7M |
| Q4 2023 | 81 | $35.5M |
| Q3 2023 | 92 | $51.7M |
| Q2 2023 | 105 | $124.8M |
| Q1 2023 | 124 | $201.7M |
| Q4 2022 | 126 | $250.6M |
| Q3 2022 | 128 | $704.6M |
| Q2 2022 | 123 | $614.6M |
| Q1 2022 | 114 | $739.1M |
| Q4 2021 | 121 | $836.1M |
| Q3 2021 | 125 | $961.9M |
| Q2 2021 | 108 | $856.1M |